National Stroke Foundation

FDA Approved Drugs by Name

Search by brand name for drugs approved by the Food and Drug Administration (FDA) for sale in the United States. Each listing contains a brief description of the indication for use. Click on the drug name for a complete product profile, including general information, clinical trial results, side effects and manufacture information.

Jakafi (ruxolitinib)

For the treatment of myelofibrosis

Jakafi (ruxolitinib)

For the treatment of steroid-refractory acute graft-versus-host disease in adults and pediatrics >12 years

Jalyn (dutasteride + tamsulosin)

For the treatment of benign prostatic hyperplasia

Januvia (sitagliptin phosphate)

For the treatment of type II diabetes

Jardiance (empagliflozin)

For the treatment of type II diabetes

Jatenzo (testosterone undecanoate)

For the treatment of male conditions associated with a deficiency or absence of endogenous testosterone

Jentadueto (linagliptin plus metformin hydrochloride)

For the treatment of type II diabetes

Jetrea (ocriplasmin)

For the treatment of symptomatic vitreomacular adhesion

Jeuveau (prabotulinumtoxinA-xvfs)

For the improvement of glabellar lines

Jevtana (cabazitaxel)

For the treatment of prostate cancer

Jivi (antihemophilic factor [recombinant] PEGylated-aucl)

For hemophilia A

Jublia (efinaconazole) 10% topical gel

For the treatment of onychomycosis of the toenails

Juluca (dolutegravir and rilpivirine)

For the treatment of HIV-1 infection in adults

Juvisync (sitagliptin and simvastatin)

For the treatment of type II diabetes

Juxtapid (lomitapide)

For the treatment of homozygous familial hypercholesterolemia

Jynarque (tolvaptan)

For the treatment of autosomal dominant polycystic kidney disease